Summary
This Form 8-K filing from DexCom, Inc. (DXCM) on March 21, 2007, details a material change in the compensation structure for its non-employee members of the Board of Directors, effective March 15, 2007. The key change involves an increase in the annual retainer, with a significant portion to be paid in company stock, aligning director incentives with shareholder interests. Notably, the filing indicates a shift away from per-meeting fees towards a more fixed annual compensation structure, with increased retainers for committee chairpersons. This move suggests a focus on long-term commitment and strategic oversight from the board, potentially signaling a period of growth and the need for dedicated board engagement. Investors should note the increased equity component in director compensation as a positive sign of management confidence.
Key Highlights
- 1Annual retainer for non-employee directors increased from $20,000 to $30,000.
- 2At least 50% of the annual retainer must be paid in DexCom stock, with up to 100% at the director's election.
- 3Per-meeting attendance fees for Board and committee meetings have been eliminated.
- 4Annual retainer for the Chairman of the Board remains unchanged at $40,000.
- 5Additional annual retainers for committee chairpersons have been increased: Nominating and Governance Committee to $10,000, Compensation Committee to $15,000, and Audit Committee to $20,000.
- 6The changes to director compensation were approved by the Board of Directors on March 15, 2007.